263 related articles for article (PubMed ID: 33393494)
21. Downregulated Wnt/β-catenin signalling in the Down syndrome hippocampus.
Granno S; Nixon-Abell J; Berwick DC; Tosh J; Heaton G; Almudimeegh S; Nagda Z; Rain JC; Zanda M; Plagnol V; Tybulewicz VLJ; Cleverley K; Wiseman FK; Fisher EMC; Harvey K
Sci Rep; 2019 May; 9(1):7322. PubMed ID: 31086297
[TBL] [Abstract][Full Text] [Related]
22. Environmental enrichment rescues DYRK1A activity and hippocampal adult neurogenesis in TgDyrk1A.
Pons-Espinal M; Martinez de Lagran M; Dierssen M
Neurobiol Dis; 2013 Dec; 60():18-31. PubMed ID: 23969234
[TBL] [Abstract][Full Text] [Related]
23. Dyrk1a activates antioxidant NQO1 expression through an ERK1/2-Nrf2 dependent mechanism.
Noll C; Tlili A; Ripoll C; Mallet L; Paul JL; Delabar JM; Janel N
Mol Genet Metab; 2012 Mar; 105(3):484-8. PubMed ID: 22178546
[TBL] [Abstract][Full Text] [Related]
24. Phosphorylation and inactivation of glycogen synthase kinase 3β (GSK3β) by dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A).
Song WJ; Song EA; Jung MS; Choi SH; Baik HH; Jin BK; Kim JH; Chung SH
J Biol Chem; 2015 Jan; 290(4):2321-33. PubMed ID: 25477508
[TBL] [Abstract][Full Text] [Related]
25. Dyrk1A overexpression in immortalized hippocampal cells produces the neuropathological features of Down syndrome.
Park J; Yang EJ; Yoon JH; Chung KC
Mol Cell Neurosci; 2007 Oct; 36(2):270-9. PubMed ID: 17720532
[TBL] [Abstract][Full Text] [Related]
26. The protein kinase DYRK1A regulates caspase-9-mediated apoptosis during retina development.
Laguna A; Aranda S; Barallobre MJ; Barhoum R; Fernández E; Fotaki V; Delabar JM; de la Luna S; de la Villa P; Arbonés ML
Dev Cell; 2008 Dec; 15(6):841-53. PubMed ID: 19081073
[TBL] [Abstract][Full Text] [Related]
27. Trisomy-driven overexpression of DYRK1A kinase in the brain of subjects with Down syndrome.
Dowjat WK; Adayev T; Kuchna I; Nowicki K; Palminiello S; Hwang YW; Wegiel J
Neurosci Lett; 2007 Feb; 413(1):77-81. PubMed ID: 17145134
[TBL] [Abstract][Full Text] [Related]
28. Dual-specificity tyrosine-phosphorylation regulated kinase 1A Gene Transcription is regulated by Myocyte Enhancer Factor 2D.
Wang P; Wang L; Chen L; Sun X
Sci Rep; 2017 Aug; 7(1):7240. PubMed ID: 28775333
[TBL] [Abstract][Full Text] [Related]
29. DYRK1A overexpression enhances STAT activity and astrogliogenesis in a Down syndrome mouse model.
Kurabayashi N; Nguyen MD; Sanada K
EMBO Rep; 2015 Nov; 16(11):1548-62. PubMed ID: 26373433
[TBL] [Abstract][Full Text] [Related]
30. The Down syndrome candidate dual-specificity tyrosine phosphorylation-regulated kinase 1A phosphorylates the neurodegeneration-related septin 4.
Sitz JH; Baumgärtel K; Hämmerle B; Papadopoulos C; Hekerman P; Tejedor FJ; Becker W; Lutz B
Neuroscience; 2008 Dec; 157(3):596-605. PubMed ID: 18938227
[TBL] [Abstract][Full Text] [Related]
31. Mechanism of dual specificity kinase activity of DYRK1A.
Walte A; Rüben K; Birner-Gruenberger R; Preisinger C; Bamberg-Lemper S; Hilz N; Bracher F; Becker W
FEBS J; 2013 Sep; 280(18):4495-511. PubMed ID: 23809146
[TBL] [Abstract][Full Text] [Related]
32. Dual-Specificity, Tyrosine Phosphorylation-Regulated Kinases (DYRKs) and cdc2-Like Kinases (CLKs) in Human Disease, an Overview.
Lindberg MF; Meijer L
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34205123
[TBL] [Abstract][Full Text] [Related]
33. The kinase DYRK1A phosphorylates the transcription factor FKHR at Ser329 in vitro, a novel in vivo phosphorylation site.
Woods YL; Rena G; Morrice N; Barthel A; Becker W; Guo S; Unterman TG; Cohen P
Biochem J; 2001 May; 355(Pt 3):597-607. PubMed ID: 11311120
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of the DYRK1A Gene (Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A) Induces Alterations of the Serotoninergic and Dopaminergic Processing in Murine Brain Tissues.
London J; Rouch C; Bui LC; Assayag E; Souchet B; Daubigney F; Medjaoui H; Luquet S; Magnan C; Delabar JM; Dairou J; Janel N
Mol Neurobiol; 2018 May; 55(5):3822-3831. PubMed ID: 28540658
[TBL] [Abstract][Full Text] [Related]
35. Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models.
Ferrer I; Barrachina M; Puig B; Martínez de Lagrán M; Martí E; Avila J; Dierssen M
Neurobiol Dis; 2005 Nov; 20(2):392-400. PubMed ID: 16242644
[TBL] [Abstract][Full Text] [Related]
36. DYRK1A BAC transgenic mouse: a new model of thyroid dysgenesis in Down syndrome.
Kariyawasam D; Rachdi L; Carré A; Martin M; Houlier M; Janel N; Delabar JM; Scharfmann R; Polak M
Endocrinology; 2015 Mar; 156(3):1171-80. PubMed ID: 25490145
[TBL] [Abstract][Full Text] [Related]
37. Targeting Dyrk1A with AAVshRNA attenuates motor alterations in TgDyrk1A, a mouse model of Down syndrome.
Ortiz-Abalia J; Sahún I; Altafaj X; Andreu N; Estivill X; Dierssen M; Fillat C
Am J Hum Genet; 2008 Oct; 83(4):479-88. PubMed ID: 18940310
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of Dyrk1A causes the defects in synaptic vesicle endocytosis.
Kim Y; Park J; Song WJ; Chang S
Neurosignals; 2010; 18(3):164-72. PubMed ID: 21135538
[TBL] [Abstract][Full Text] [Related]
39. DYRK1A in Down syndrome: an oncogene or tumor suppressor?
Birger Y; Izraeli S
J Clin Invest; 2012 Mar; 122(3):807-10. PubMed ID: 22354166
[TBL] [Abstract][Full Text] [Related]
40. Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A (DYRK1A) Inhibitors as Potential Therapeutics.
Jarhad DB; Mashelkar KK; Kim HR; Noh M; Jeong LS
J Med Chem; 2018 Nov; 61(22):9791-9810. PubMed ID: 29985601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
